Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00726_DB01601> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00726_DB01601 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00726_DB01601 label "DDI between Trimipramine and Lopinavir - The strong CYP3A4/CYP2D6 inhibitor, Lopinavir, may decrease the metabolism and clearance of Trimipramine, a CYP3A4/CYP2D6 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Lopinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00726_DB01601]" assertion.
- drugbank_resource:DB00726_DB01601 identifier "drugbank_resource:DB00726_DB01601" assertion.
- drugbank_resource:DB00726_DB01601 title "DDI between Trimipramine and Lopinavir - The strong CYP3A4/CYP2D6 inhibitor, Lopinavir, may decrease the metabolism and clearance of Trimipramine, a CYP3A4/CYP2D6 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimipramine if Lopinavir is initiated, discontinued or dose changed." assertion.